Amyris

Amyris Capital Intensity

Delisted·May 7, 2024

The Capital Intensity Ratio of Amyris (AMRSQ) as of Nov 21, 2026 is 305.70 %. In the previous year, Capital Intensity Ratio was 279.18 % — a change of 9.50% (higher).

Capital Intensity

305.70 %

YoY

9.50%

Last updated:

Capital Intensity Ratio of Amyris is 2022 305.70 % . Capital Intensity Ratio of Amyris was 2021 279.18 % . It decreases by 9.50% higher compared to the previous year.

The Amyris Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2015
310.23 USD
Jan 1, 2016
193.30 USD
Jan 1, 2017
110.26 USD
Jan 1, 2018
201.10 USD
Jan 1, 2019
105.51 USD
Jan 1, 2020
128.69 USD
Jan 1, 2021
279.18 USD
Jan 1, 2022
305.70 USD
The Amyris Capital Intensity history
YEARCapital IntensityYoY
305.70 %+9.50%
279.18 %+116.94%
128.69 %+21.97%
105.51 %-47.53%
201.10 %+82.39%
110.26 %-42.96%
193.30 %-37.69%
310.23 %-37.87%
499.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

Capital Intensity Ratio of Amyris is 305.70 % in 2022.

Capital Intensity Ratio of Amyris changed from 279.18 % to 305.70 %, representing a 9.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Amyris since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Amyris with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Amyris

All Key Metrics — Amyris